Automating Genetic Testing Imaging Prior Auth

Klivira automates the complex landscape of **genetic testing imaging prior auth**, ensuring patients receive timely access to critical diagnostic and surveillance imaging.

For clinics managing genetic testing patients, securing prior authorization for advanced imaging can be a significant bottleneck. From hereditary cancer panels requiring intensified surveillance to prenatal diagnostics, these imaging orders often route through specialized radiology benefit managers, introducing delays and administrative burden. Klivira streamlines this intricate process, integrating directly with your EMR to accelerate approvals.

The Challenge of Imaging PA in Genetic Testing

Genetic testing often identifies risks (e.g., hereditary cancer panels like BRCA) necessitating rigorous imaging surveillance (e.g., breast MRI, abdominal MRI, PET). These advanced imaging orders frequently trigger prior authorization requirements, often managed by third-party radiology benefit managers (RBMs) such as eviCore, Avalon Healthcare Services, NIA Magellan, or Carelon Medical Benefits Management (formerly AIM).

Common Genetic Testing Imaging PA Triggers

Surveillance imaging for hereditary cancer syndromes (e.g., annual breast MRI for BRCA carriers).
Diagnostic imaging for suspected malignancies identified through genetic predispositions.
Advanced fetal imaging (e.g., detailed ultrasound, fetal MRI) following prenatal genetic screening.
Imaging to monitor treatment efficacy or side effects influenced by pharmacogenomic insights.
Pre-surgical imaging for patients undergoing risk-reducing procedures based on genetic test results.

Navigating RBMs and Payer Requirements

The imaging prior authorization process for genetic testing patients is further complicated by the diverse landscape of RBMs. Each RBM, including eviCore, NIA Magellan, and Carelon Medical Benefits Management, operates distinct portals and applies specific medical necessity criteria, often leveraging frameworks like ACR Appropriateness Criteria. Incorrect routing or incomplete submissions lead to significant delays and peer-to-peer review volume.

Klivira's Automated Workflow for Genetic Testing Imaging PA

**EMR-integrated detection**: Klivira identifies advanced imaging orders at the point of clinician entry, leveraging CDS Hooks for real-time PA requirement checks.
**Intelligent RBM routing**: Automatically directs submissions to the correct RBM (e.g., eviCore, NIA Magellan, Carelon Medical Benefits Management) or payer-direct channel, eliminating manual vendor identification errors.
**Pre-submission appropriateness checks**: Evaluates orders against ACR Appropriateness Criteria, surfacing alternative imaging recommendations to clinicians before submission to prevent denials.
**Automated data population**: Extracts clinical documentation, ICD-10 diagnoses, and prior imaging history from FHIR data to populate submission forms efficiently.
**Streamlined response handling**: Manages approvals, modifications, and routes denials to an integrated peer-to-peer scheduling workflow.

Reducing Administrative Burden and Patient Delays

By automating the **genetic testing imaging prior auth** workflow, Klivira significantly reduces the administrative burden on PA coordinators and revenue cycle teams. This automation minimizes manual portal navigation, accelerates submission times, and proactively addresses common denial reasons, ultimately improving patient throughput and reducing delays for critical diagnostic and surveillance imaging.

Seamless EMR Integration and Standards Compliance

Klivira integrates with leading EMR systems, utilizing standards such as Da Vinci CRD for coverage requirements discovery and Da Vinci PAS for conformant payer submissions. Our platform also supports X12 278 for EDI transactions, ensuring robust connectivity across diverse payer and RBM ecosystems while adhering to industry best practices for PHI security.

Frequently asked questions

How does Klivira handle different RBMs for genetic testing imaging PA?

Klivira's platform includes an intelligent routing engine that identifies the correct RBM (e.g., eviCore, NIA Magellan, Carelon Medical Benefits Management) based on payer and member plan, automatically submitting the prior authorization request to the appropriate portal or Da Vinci PAS endpoint. This eliminates manual vendor identification errors.

Can Klivira help with imaging orders related to hereditary cancer panels?

Yes, Klivira is specifically designed to automate prior authorizations for advanced imaging triggered by hereditary cancer panels, such as annual breast MRIs for BRCA carriers. Our system checks these orders against medical necessity criteria and ensures timely submission to relevant RBMs.

What clinical criteria does Klivira use for imaging appropriateness?

Klivira integrates ACR Appropriateness Criteria to evaluate imaging orders for medical necessity prior to submission. This allows our platform to proactively identify potential appropriateness gaps and recommend alternative imaging options to clinicians, reducing denials and peer-to-peer volumes.

How does Klivira reduce delays for genetic testing patients needing imaging?

By automating PA requirement detection at order entry, intelligently routing submissions, and conducting pre-submission appropriateness checks, Klivira significantly reduces the manual steps and common failure modes that cause delays. This accelerates the PA cycle time, allowing imaging to be scheduled faster for genetic testing patients.

Is Klivira compatible with our EMR for genetic testing imaging orders?

Klivira integrates with major EMR systems using standards like SMART on FHIR, Da Vinci CRD, and Da Vinci PAS. This ensures seamless data exchange for advanced imaging orders, including those originating from genetic testing workflows, enabling automated PA initiation directly from your existing EMR environment.